Absolute risk of a subsequent abnormal pap among oncogenic human papillomavirus DNA-positive, cytologically negative women.
about
Genomic amplification of the human telomerase gene (TERC) in pap smears predicts the development of cervical cancerDownregulation of Cdc2/CDK1 kinase activity induces the synthesis of noninfectious human papillomavirus type 31b virions in organotypic tissues exposed to benzo[a]pyrene.Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistenceTranslational approaches to improving cervical screening.Detection of genomic amplification of the human telomerase gene (TERC) in cytologic specimens as a genetic test for the diagnosis of cervical dysplasiaLong-term outcomes of high-risk human papillomavirus infection support a long interval of cervical cancer screening.Kinetics of DNA load predict HPV 16 viral clearance.Quantitative human papillomavirus 16 and 18 levels in incident infections and cervical lesion development.Worldwide incidence of cervical lesions: a systematic review.[Detection of high risk human papillomavirus by hybrid capture II® according cytological findings in women treated for squamous intraepithelial lesions of the cervix, period 2006/2010].Rationale and design of the HOME trial: A pragmatic randomized controlled trial of home-based human papillomavirus (HPV) self-sampling for increasing cervical cancer screening uptake and effectiveness in a U.S. healthcare system.CHAPTER 7 Methods for detection of HPV infection and its clinical utility.Understanding Human Papillomavirus
P2860
Q24675639-62384E46-E0BD-45C5-A4AD-547DD3E809A5Q33826637-3EC3C952-3F02-418A-9BB8-EF0592C18E89Q34176414-A6D47B7A-3389-4C29-A034-D3D88C651314Q35075785-33324C11-481B-4E8F-A081-5B35709AB359Q35792128-92ECA043-24C2-4DD1-9BDD-CC1999C667D0Q36494175-23D02278-32BF-4E6A-AD29-F1697AB9FA8BQ37334772-8CBA8F55-0326-45E9-B39C-3696ED2CF9D1Q37699247-7FC93F94-C4D8-47FA-AA98-D792D009313FQ38216073-2842AEC8-DDEE-4D32-8B73-DB07C7B3955FQ45280381-A21E4D6E-BF9C-4A60-8C76-DCD09487772EQ46087962-847C5B70-0BA0-44AB-BDDE-136F49650D24Q54573717-037AA707-6EBA-47D2-A437-B5F09E74AC99Q58302484-721C433B-A091-4689-9206-D4A33D5E0A88
P2860
Absolute risk of a subsequent abnormal pap among oncogenic human papillomavirus DNA-positive, cytologically negative women.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Absolute risk of a subsequent ...... cytologically negative women.
@en
Absolute risk of a subsequent ...... cytologically negative women.
@nl
type
label
Absolute risk of a subsequent ...... cytologically negative women.
@en
Absolute risk of a subsequent ...... cytologically negative women.
@nl
prefLabel
Absolute risk of a subsequent ...... cytologically negative women.
@en
Absolute risk of a subsequent ...... cytologically negative women.
@nl
P2093
P2860
P356
P1433
P1476
Absolute risk of a subsequent ...... cytologically negative women.
@en
P2093
Andrew G Glass
Attila T Lorincz
Brenda B Rush
David R Scott
Franklin Demuth
Mark E Sherman
Philip E Castle
P2860
P304
P356
10.1002/CNCR.10927
P407
P577
2002-11-01T00:00:00Z